119 related articles for article (PubMed ID: 36734072)
1. The molecular mechanism of γ-aminobutyric acid against AD: the role of CEBPα/circAPLP2/miR-671-5p in regulating CNTN1/2 expression.
Meng N; Pan P; Hu S; Miao C; Hu Y; Wang F; Zhang J; An L
Food Funct; 2023 Feb; 14(4):2082-2095. PubMed ID: 36734072
[TBL] [Abstract][Full Text] [Related]
2. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.
Liu J; Zhang J; Wang Z; Xi J; Bai L; Zhang Y
Cancer Biother Radiopharm; 2021 Nov; 36(9):737-752. PubMed ID: 32343603
[No Abstract] [Full Text] [Related]
4. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1.
Zhu M; Jia L; Jia J
J Alzheimers Dis; 2021; 83(1):367-377. PubMed ID: 34334400
[TBL] [Abstract][Full Text] [Related]
5. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
Li Q; Li X; Wang L; Zhang Y; Chen L
J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
7. miR-16-5p is upregulated by amyloid β deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
Kim YJ; Kim SH; Park Y; Park J; Lee JH; Kim BC; Song WK
Exp Gerontol; 2020 Jul; 136():110954. PubMed ID: 32320719
[TBL] [Abstract][Full Text] [Related]
8. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease.
Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R
Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-34a by Inhibition of IRE1
Li Q; Liu T; Yang S; Zhang Z
Oxid Med Cell Longev; 2019; 2019():2140427. PubMed ID: 31281568
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
12. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
13. miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling.
Zhan-Qiang H; Hai-Hua Q; Chi Z; Miao W; Cui Z; Zi-Yin L; Jing H; Yi-Wei W
Neurologia (Engl Ed); 2023 Sep; 38(7):486-494. PubMed ID: 37659839
[TBL] [Abstract][Full Text] [Related]
14. MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-κB signaling.
Shao P
Brain Res; 2021 Sep; 1766():147511. PubMed ID: 33957091
[TBL] [Abstract][Full Text] [Related]
15. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy.
Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732
[TBL] [Abstract][Full Text] [Related]
17. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
18. miRNA-137-5p improves spatial memory and cognition in Alzheimer's mice by targeting ubiquitin-specific peptidase 30.
Jiang Y; Bian W; Chen J; Cao X; Dong C; Xiao Y; Xu B; Sun X
Animal Model Exp Med; 2023 Dec; 6(6):526-536. PubMed ID: 38111333
[TBL] [Abstract][Full Text] [Related]
19. LncRNA Rpph1 protects amyloid-β induced neuronal injury in SK-N-SH cells via miR-122/Wnt1 axis.
Gu R; Wang L; Tang M; Li SR; Liu R; Hu X
Int J Neurosci; 2020 May; 130(5):443-453. PubMed ID: 31718352
[No Abstract] [Full Text] [Related]
20. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
